Phenylephrine/ketorolac
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Phenylephrine | Alpha-1 adrenergic receptor agonist |
| Ketorolac | Nonsteroidal anti-inflammatory |
| Clinical data | |
| Trade names | Omidria |
| AHFS/Drugs.com | Monograph |
| License data | |
| Routes of administration |
Intraocular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
Phenylephrine/ketorolac, sold under the brand name Omidria, is a combination drug used during cataract surgery or intraocular lens replacement to prevent intraoperative miosis and to reduce postoperative pain. It contains phenylephrine and ketorolac.
Phenylephrine/ketorolac was approved for medical use in the United States in May 2014, and in the European Union in July 2015.
External links
- "Ketorolac mixture with phenylephrine". Drug Information Portal. U.S. National Library of Medicine.
|
Receptor (ligands) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Enzyme (inhibitors) |
|
||||||||||||||||||||||||||
| Others | |||||||||||||||||||||||||||